These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27241104)

  • 1. Lynch Syndrome: Female Genital Tract Cancer Diagnosis and Screening.
    Mills AM; Longacre TA
    Surg Pathol Clin; 2016 Jun; 9(2):201-14. PubMed ID: 27241104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory Assays in Evaluation of Lynch Syndrome in Patients with Endometrial Carcinoma.
    Djordjevic B; Broaddus RR
    Surg Pathol Clin; 2016 Jun; 9(2):289-99. PubMed ID: 27241109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lynch Syndrome Screening in the Gynecologic Tract: Current State of the Art.
    Mills AM; Longacre TA
    Am J Surg Pathol; 2016 Apr; 40(4):e35-44. PubMed ID: 26872009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
    Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K
    BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
    Kahn RM; Gordhandas S; Maddy BP; Baltich Nelson B; Askin G; Christos PJ; Caputo TA; Chapman-Davis E; Holcomb K; Frey MK
    Cancer; 2019 Sep; 125(18):3172-3183. PubMed ID: 31150123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers.
    Kim SR; Tone A; Kim R; Cesari M; Clarke B; Eiriksson L; Hart T; Aronson M; Holter S; Lytwyn A; Maganti M; Oldfield L; Gallinger S; Bernardini MQ; Oza AM; Djordjevic B; Lerner-Ellis J; Van de Laar E; Vicus D; Pugh TJ; Pollett A; Ferguson SE
    Int J Gynecol Cancer; 2020 Dec; 30(12):1951-1958. PubMed ID: 33082239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mismatch repair deficiency testing in clinical practice.
    Buza N; Ziai J; Hui P
    Expert Rev Mol Diagn; 2016; 16(5):591-604. PubMed ID: 26895074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future role of genetic screening in gynecologic malignancies.
    Ring KL; Garcia C; Thomas MH; Modesitt SC
    Am J Obstet Gynecol; 2017 Nov; 217(5):512-521. PubMed ID: 28411145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age.
    Goverde A; Spaander MC; van Doorn HC; Dubbink HJ; van den Ouweland AM; Tops CM; Kooi SG; de Waard J; Hoedemaeker RF; Bruno MJ; Hofstra RM; de Bekker-Grob EW; Dinjens WN; Steyerberg EW; Wagner A;
    Gynecol Oncol; 2016 Dec; 143(3):453-459. PubMed ID: 27789085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers.
    Kim SR; Tone A; Kim R; Cesari M; Clarke B; Hart T; Aronson M; Holter S; Lytwyn A; Maganti M; Oldfield L; Gallinger S; Bernardini MQ; Oza AM; Djordjevic B; Lerner-Ellis J; Van de Laar E; Vicus D; Pugh TJ; Pollett A; Ferguson SE; Eiriksson L
    Int J Gynecol Cancer; 2022 Jul; 32(7):891-898. PubMed ID: 35012974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers.
    Shaw PA; Clarke BA
    Surg Pathol Clin; 2016 Jun; 9(2):307-28. PubMed ID: 27241111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite instability analysis for the screening of synchronous endometrial and ovarian cancer in Lynch syndrome.
    Bats AS; Roussel H; Narjoz C; Le Frere-Belda MA; Chamming's F; Blons H; Laurent-Puig P; Lecuru F
    Anticancer Res; 2013 Sep; 33(9):3977-81. PubMed ID: 24023337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
    Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
    Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
    Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Muir-Torre syndrome--a phenotypic variant of Lynch syndrome].
    Kacerovská D; Kazakov DV; Cerná K; Hadravský L; Michal M; Dostál J; Skálová A; Michal M
    Cesk Patol; 2010 Oct; 46(4):86-94. PubMed ID: 21313735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified identification of Lynch syndrome: a prospective, multicenter study.
    Bonnet D; Selves J; Toulas C; Danjoux M; Duffas JP; Portier G; Kirzin S; Ghouti L; Carrère N; Suc B; Alric L; Barange K; Buscail L; Chaubard T; Imani K; Guimbaud R
    Dig Liver Dis; 2012 Jun; 44(6):515-22. PubMed ID: 22480969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of mismatch repair deficiency in ovarian cancer.
    Crosbie EJ; Ryan NAJ; McVey RJ; Lalloo F; Bowers N; Green K; Woodward ER; Clancy T; Bolton J; Wallace AJ; McMahon RF; Evans DG
    J Med Genet; 2021 Oct; 58(10):687-691. PubMed ID: 32917768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
    Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
    Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome.
    Mas-Moya J; Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK
    Hum Pathol; 2015 Nov; 46(11):1616-25. PubMed ID: 26319271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular changes preceding endometrial and ovarian cancer: a study of consecutive endometrial specimens from Lynch syndrome surveillance.
    Niskakoski A; Pasanen A; Lassus H; Renkonen-Sinisalo L; Kaur S; Mecklin JP; Bützow R; Peltomäki P
    Mod Pathol; 2018 Aug; 31(8):1291-1301. PubMed ID: 29588532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.